Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in moroccans

• Published in: Clinical and experimental hypertension (1993) Vol. 27; no. 4; pp. 377 - 394
• Main Authors: LYOUSSI, B, RAGALA, M. A, M'GUIL, M, CHRAIBI, A, ISRAILI, Zafar H
• Format: Journal Article
• Language: English
• Published: Colchester Taylor & Francis 01.05.2005
• Subjects: Aged; Arterial hypertension. Arterial hypotension; Biological and medical sciences; Blood and lymphatic vessels; Blood coagulation. Blood cells; Blood Glucose; Blood Pressure; Body Mass Index; C-Peptide - blood; Cardiology. Vascular system; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - ethnology; Female; Fundamental and applied biological sciences. Psychology; Humans; Hypertension - blood; Hypertension - ethnology; Insulin - blood; Insulin Resistance; Insulin-Like Growth Factor I - metabolism; Leptin - blood; Lipids - blood; Male; Medical sciences; Metabolic Syndrome - blood; Metabolic Syndrome - ethnology; Middle Aged; Molecular and cellular biology; Morocco; Obesity - blood; Obesity - ethnology; Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ; Platelet; Sex Characteristics; Uric Acid - blood; Vertebrates: nervous system and sense organs; Hypertension; metabolic syndrome; Body mass index; Leptin; Cardiovascular disease; Insulin; diabetes
• ISSN: 1064-1963; 1525-6006
• DOI: 10.1081/CEH-200057441

The levels of the liporegulatory hormone leptin are increased in obesity, which contributes to the metabolic syndrome; the latter is associated with elevated cardiovascular risk and morbidity. Leptin may play a role in the metabolic syndrome since correlations have been observed between serum leptin levels and several components of the metabolic syndrome. The association of leptinemia and hypertension or diabetes is inconsistent. Leptin levels are higher in females versus males and obese versus lean individuals. We investigated if correlations exist between leptin levels and several indices of the metabolic syndrome in obese and lean Moroccan subjects with (63 males, 129 females) and without (123 males, 234 females) diabetes and/or hypertension. Plasma glucose and insulin and systolic and diastolic blood pressures were higher in obese versus lean individuals. Obesity had no effect on lipid profile, plasma IGF-1, or C-peptide levels. Leptin levels were higher in females versus males and in obese versus lean individuals. The levels correlated significantly with body mass index. Serum leptin concentration did not correlate with either systolic or diastolic blood pressure, although there was a trend for higher blood pressure with increased leptin levels in females. There was no significant difference in leptin levels between NIDDM patients and healthy controls. However, in hypertensive patients, leptin levels were significantly higher in both lean males and females with diabetes as compared to those without diabetes. Similarly, the higher leptin levels paralleled elevated insulin levels in obese nondiabetic males and females, and in male and female diabetics with hypertension. Correlations were observed between leptin levels and C-peptide (an estimate of endogenous insulin secretion), but not with serum IGF-1. The calculated values of HOMA-IR, a marker of insulin resistance, were somewhat higher, parallel with elevated leptin levels, in obese male and female individuals compared to their lean counterparts. There was no relationship between leptin levels and serum lipids. There was a trend for increased serum uric acid levels with higher leptin concentrations. Thus, leptinemia is related to some components of metabolic syndrome, and in turn, it may contribute to the syndrome. This study is novel in that relationships were determined between leptin levels and various indices of metaboli syndrome in a large population of the same ethnic/regional background.